Skip to main navigation Skip to search Skip to main content

Cellular origin and microRNA profiles of circulating extracellular vesicles in different stages of diabetic nephropathy

  • Melissa Uil
  • , Chi M Hau
  • , Mohamed Ahdi
  • , James D Mills
  • , Jesper Kers
  • , Moin A Saleem
  • , Sandrine Florquin
  • , Victor E A Gerdes
  • , Rienk Nieuwland
  • , Joris J T H Roelofs

    Research output: Contribution to journal › Article (Academic Journal) › peer-review

    28 Citations (Scopus)
    103 Downloads (Pure)

    Abstract

    Background: Diabetic nephropathy (DN) is a major complication of diabetes and the main cause of end-stage renal disease. Extracellular vesicles (EVs) are small cell-derived vesicles that can alter disease progression by microRNA (miRNA) transfer.

    Methods: In this study, we aimed to characterize the cellular origin and miRNA content of EVs in plasma samples of type 2 diabetes patients at various stages of DN. Type 2 diabetes patients were classified in three groups: normoalbuminuria, microalbuminuria and macroalbuminuria. The concentration and cellular origin of plasma EVs were measured by flow cytometry. A total of 752 EV miRNAs were profiled in 18 subjects and differentially expressed miRNAs were validated.

    Results: Diabetic patients with microalbuminuria and/or macroalbuminuria showed elevated concentrations of total EVs and EVs from endothelial cells, platelets, leucocytes and erythrocytes compared with diabetic controls. miR-99a-5p was upregulated in macroalbuminuric patients compared with normoalbuminuric and microalbuminuric patients. Transfection of miR-99a-5p in cultured human podocytes downregulated mammalian target of rapamycin (mTOR) protein expression and downregulated the podocyte injury marker vimentin.

    Conclusions: Type 2 diabetes patients with microalbuminuria and macroalbuminuria display differential EV profiles. miR-99a-5p expression is elevated in EVs from macroalbuminuria and mTOR is its validated mRNA target.

    Original languageEnglish
    Pages (from-to)358-365
    Number of pages8
    JournalClinical Kidney Journal
    Volume14
    Issue number1
    Early online date23 Oct 2019
    DOIs
    Publication statusPublished - Jan 2021

    Bibliographical note

    © The Author(s) 2019. Published by Oxford University Press on behalf of ERA-EDTA.

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Fingerprint

    Dive into the research topics of 'Cellular origin and microRNA profiles of circulating extracellular vesicles in different stages of diabetic nephropathy'. Together they form a unique fingerprint.

    Cite this